RetroSearch Browse

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/27211498/ below:

Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test

. 2016 Oct;14(10):1445-1451.e8. doi: 10.1016/j.cgh.2016.05.017. Epub 2016 May 19. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test

Affiliations

¹ Department of Public Health, Erasmus MC University Medical Center, Rotterdam, Netherlands. Electronic address: r.meester@erasmusmc.nl.
² Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
³ Department of Family Medicine and Community Health and Department of Epidemiology, Perelman School of Medicine, and Leonard Davis Institute of Health Economics and Center for Public Health Initiatives, University of Pennsylvania, Philadelphia, Pennsylvania.
⁴ Kaiser Permanente Division of Research, Oakland, California.
⁵ Kaiser Permanente Southern California, Research and Evaluation, Pasadena, California.
⁶ Veterans Affairs Portland Healthcare System, Portland, Oregon.
⁷ Veterans Affairs Puget Sound Healthcare System, Seattle, Washington; Division of Gastroenterology, University of Washington School of Medicine, Seattle, Washington.
⁸ Department of Public Health, Erasmus MC University Medical Center, Rotterdam, Netherlands.

PMID: 27211498
PMCID: PMC5028249
DOI: 10.1016/j.cgh.2016.05.017

Item in Clipboard

Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test

Reinier G S Meester et al. Clin Gastroenterol Hepatol. 2016 Oct.

. 2016 Oct;14(10):1445-1451.e8. doi: 10.1016/j.cgh.2016.05.017. Epub 2016 May 19. Affiliations

¹ Department of Public Health, Erasmus MC University Medical Center, Rotterdam, Netherlands. Electronic address: r.meester@erasmusmc.nl.
² Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
³ Department of Family Medicine and Community Health and Department of Epidemiology, Perelman School of Medicine, and Leonard Davis Institute of Health Economics and Center for Public Health Initiatives, University of Pennsylvania, Philadelphia, Pennsylvania.
⁴ Kaiser Permanente Division of Research, Oakland, California.
⁵ Kaiser Permanente Southern California, Research and Evaluation, Pasadena, California.
⁶ Veterans Affairs Portland Healthcare System, Portland, Oregon.
⁷ Veterans Affairs Puget Sound Healthcare System, Seattle, Washington; Division of Gastroenterology, University of Washington School of Medicine, Seattle, Washington.
⁸ Department of Public Health, Erasmus MC University Medical Center, Rotterdam, Netherlands.

PMID: 27211498
PMCID: PMC5028249
DOI: 10.1016/j.cgh.2016.05.017

Item in Clipboard

Erratum in

Correction.
[No authors listed] [No authors listed] Clin Gastroenterol Hepatol. 2018 May;16(5):787. doi: 10.1016/j.cgh.2018.02.023. Clin Gastroenterol Hepatol. 2018. PMID: 29678243 No abstract available.
Correction.
[No authors listed] [No authors listed] Clin Gastroenterol Hepatol. 2018 Aug;16(8):1365. doi: 10.1016/j.cgh.2018.06.001. Clin Gastroenterol Hepatol. 2018. PMID: 30033180 No abstract available.

Abstract

Background & aims: Delays in diagnostic testing after a positive result from a screening test can undermine the benefits of colorectal cancer (CRC) screening, but there are few empirical data on the effects of such delays. We used microsimulation modeling to estimate the consequences of time to colonoscopy after a positive result from a fecal immunochemical test (FIT).

Methods: We used an established microsimulation model to simulate an average-risk United States population cohort that underwent annual FIT screening (from ages 50 to 75 years), with follow-up colonoscopy examinations for individuals with positive results (cutoff, 20 μg/g) at different time points in the following 12 months. Main evaluated outcomes were CRC incidence and mortality; additional outcomes were total life-years lost and net costs of screening.

Results: For individuals who underwent diagnostic colonoscopy within 2 weeks of a positive result from an FIT, the estimated lifetime risk of CRC incidence was 35.5/1000 persons, and mortality was 7.8/1000 persons. Every month added until colonoscopy was associated with a 0.1/1000 person increase in cancer incidence risk (an increase of 0.3%/month, compared with individuals who received colonoscopies within 2 weeks) and mortality risk (increase of 1.4%/month). Among individuals who received colonoscopy examinations 12 months after a positive result from an FIT, the incidence of CRC was 37.0/1000 persons (increase of 4%, compared with 2 weeks), and mortality was 9.1/1000 persons (increase of 16%). Total years of life gained for the entire screening cohort decreased from an estimated 93.7/1000 persons with an almost immediate follow-up colonoscopy (cost savings of $208 per patient, compared with no colonoscopy) to 84.8/1000 persons with follow-up colonoscopies at 12 months (decrease of 9%; cost savings of $100/patient, compared with no colonoscopy).

Conclusions: By using a microsimulation model of an average-risk United States screening cohort, we estimated that delays of up to 12 months after a positive result from an FIT can produce proportional losses of up to nearly 10% in overall screening benefits. These findings indicate the importance of timely follow-up colonoscopy examinations of patients with positive results from FITs.

Keywords: Colorectal Neoplasms; Occult Blood; Screening and Early Detection; Time Factors.

PubMed Disclaimer

Figures
Figure 1

Figure 1a,b. Lifetime colorectal cancer…

Figure 1

Figure 1a,b. Lifetime colorectal cancer incidence (a) and mortality (b) in FIT positive…

Figure 1

Figure 1a,b. Lifetime colorectal cancer incidence (a) and mortality (b) in FIT positive patients. ^aRelative to the scenario of follow-up within two weeks from a positive result.

Figure 1

Figure 1a,b. Lifetime colorectal cancer…

Figure 1

Figure 1a,b. Lifetime colorectal cancer incidence (a) and mortality (b) in FIT positive…

Figure 1

Figure 1a,b. Lifetime colorectal cancer incidence (a) and mortality (b) in FIT positive patients. ^aRelative to the scenario of follow-up within two weeks from a positive result.

Figure 2

Stages of newly diagnosed colorectal…

Figure 2

Stages of newly diagnosed colorectal cancer cases in FIT positive patients according to…

Figure 2

Stages of newly diagnosed colorectal cancer cases in FIT positive patients according to time to diagnostic colonoscopy.

Figure 3

Estimated mortality increase per additional…

Figure 3

Estimated mortality increase per additional month to diagnostic colonoscopy in patients with a…

Figure 3

Estimated mortality increase per additional month to diagnostic colonoscopy in patients with a positive fecal test, under various scenarios. Abbreviation: CRC = colorectal cancer; pp = percentage point. ^aEffects relative to the scenario of follow-up within two weeks from a positive result are presented within parentheses. ^bSee Supplementary Table 1 for the assumed test characteristics. ^cSee Supplementary Table 1 for assumed uncertainty in FIT and colonoscopy sensitivity according to lesion size or stage.